Otolaryngology Doctors in Jonesboro, AR Accepting Medicare

6 Otolaryngology doctors found. Showing 1 - 6

Bryan K Lansford, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4802 E Johnson Ave, Jonesboro, AR 72401 Phone: 870-936-8000    Fax: 870-934-3637

Gary W Woodward, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 621 E Matthews, Jonesboro, AR 72401 Phone: 870-932-6799    Fax: 870-932-8423

Dr. Shane R Smith, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 621 E Matthews Ave, Jonesboro, AR 72401 Phone: 870-932-6799    Fax: 870-932-8423

Dr. David Lewis, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 621 E Matthews Ave, Jonesboro, AR 72401 Phone: 870-932-6799    Fax: 870-932-8423

Dr. Joseph H Sales, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 621 E Matthews Ave, Jonesboro, AR 72401 Phone: 870-932-6799    Fax: 870-932-8423

Dr. John B Jiu, MD Otolaryngology - Otolaryngology/Facial Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 621 E Matthews Ave, Jonesboro, AR 72401 Phone: 870-932-6799    Fax: 870-932-8423

News Archive

FDA grants approval for first drug to treat inherited breast cancer

The U.S. Food and Drug Administration today expanded the approved use of Lynparza (olaparib tablets) to include the treatment of patients with certain types of breast cancer that have spread (metastasized) and whose tumors have a specific inherited (germline) genetic mutation, making it the first drug in its class (PARP inhibitor) approved to treat breast cancer, and it is the first time any drug has been approved to treat certain patients with metastatic breast cancer who have a "BRCA" gene mutation.

Study investigates concept of 'additionality' in domestic health spending amid foreign donations

In this study published in Health Affairs this month, researchers investigated the concept known as "additionality," where donor nations and philanthropic organizations "require that funds provided for a specific health priority such as HIV should supplement domestic spending on that priority."

Lead even below level "of concern" for children may impair kidney function

Small amounts of lead in the bodies of healthy children and teens — amounts well below the levels defined as "concerning" by the U.S. Centers for Disease Control and Prevention (CDC) — may worsen kidney function, according to a Johns Hopkins Children's Center study published in the Jan. 11 issue of Archives of Internal Medicine.

Acupuncture can affect severity of hot flashes for women in natural menopause

In the 2,500+ years that have passed since acupuncture was first used by the ancient Chinese, it has been used to treat a number of physical, mental and emotional conditions including nausea and vomiting, stroke rehabilitation, headaches, menstrual cramps, asthma, carpal tunnel, fibromyalgia and osteoarthritis, to name just a few.

TESARO secures $60 million in start-up funding to acquire, develop and commercialize cancer therapeutics

TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that it has secured $60 million in start-up funding to acquire, develop and commercialize cancer therapeutics and supportive care products. Participants in a $20 million Series A financing included New Enterprise Associates (NEA) and TESARO management; additionally, NEA has reserved $40 million to support company growth.

Read more Medical News

› Verified 8 days ago